Detalles de la búsqueda
1.
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
N Engl J Med
; 385(18): 1643-1655, 2021 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34449185
2.
Complementary evidence on the performance of coronary stents generated by a randomized controlled trial and a worldwide registry.
Am Heart J
; 261: 35-44, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36931370
3.
Sex-based treatment and outcomes for coronary bifurcation stenting: A report from the e-ULTIMASTER registry.
Catheter Cardiovasc Interv
; 102(3): 430-439, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37464969
4.
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.
Circulation
; 144(15): 1196-1211, 2021 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34455849
5.
Safety and efficacy of 48 mm Xience Xpedition everolimus-eluting stent for the treatment of long coronary lesions.
Catheter Cardiovasc Interv
; 100(2): 179-187, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35621281
6.
Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
Catheter Cardiovasc Interv
; 99(4): 1047-1058, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35170843
7.
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease.
Eur Heart J
; 42(23): 2265-2269, 2021 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33822924
8.
Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
Catheter Cardiovasc Interv
; 98(3): 511-519, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33211387
9.
Imaging and 2-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold: The MeRes-1 extend trial.
Catheter Cardiovasc Interv
; 98(6): 1102-1110, 2021 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33269506
10.
Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial.
Catheter Cardiovasc Interv
; 95(2): 175-184, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31033154
11.
Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.
Circulation
; 137(5): 464-479, 2018 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29089314
12.
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.
Am Heart J
; 209: 97-105, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30703644
13.
Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center.
Catheter Cardiovasc Interv
; 93(7): 1367-1373, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30536569
14.
Effect of Carbon Insertion on the Structural and Magnetic Properties of NdScSi.
Inorg Chem
; 58(22): 15255-15268, 2019 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31674174
15.
Angiographic late lumen loss revisited: impact on long-term target lesion revascularization.
Eur Heart J
; 39(36): 3381-3389, 2018 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30124834
16.
Fracture of the delivery balloon shaft during balloon-expandable prosthesis alignment during implantation of an Edwards SAPIEN 3.
Catheter Cardiovasc Interv
; 91(5): 997-999, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27142180
17.
Hydrogen Insertion in the Intermetallic GdScGe: A Drastic Reduction of the Dimensionality of the Magnetic and Transport Properties.
Inorg Chem
; 57(22): 14230-14239, 2018 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407001
18.
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
Lancet
; 388(10059): 2479-2491, 2016 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806897
19.
Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
Catheter Cardiovasc Interv
; 90(7): 1192-1197, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28295996
20.
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
Lancet
; 385(9962): 43-54, 2015 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25230593